| Literature DB >> 33154925 |
Hesham A Naeim1,2, Reda Abuelatta1, Faisal O Alatawi1,3, Lamiaa Khedr1,4.
Abstract
BACKGROUND: Chronic pressure overload secondary to severe aortic stenosis causes impairment of left ventricular myocardial deformation and associated with adverse outcome. The present study aimed to assess the response of myocardial mechanics after transcatheter aortic valve implantation (TAVI).Entities:
Year: 2020 PMID: 33154925 PMCID: PMC7640549 DOI: 10.37616/2212-5043.1065
Source DB: PubMed Journal: J Saudi Heart Assoc ISSN: 1016-7315
Clinical characteristics.
| Clinical characteristics | All Patients (n = 80) | LVEF<50% Group A (n = 34) | LVEF>50 Group B (n = 46) | P |
|---|---|---|---|---|
| Age | 80 ± 11 | 79 ± 12 | 80 ± 10 | 0.65 |
| Gender | ||||
| Male | 55(68.8%) | 27(79.40%) | 28(60.9%) | 0.08 |
| Female | 25(31.30%) | 7(20.60%) | 18(39.10%) | |
| BSA | 30.5 ± 7.1 | 30.3 ± 7.0 | 30.6 ± 7.2 | 0.8 |
| BMI | 1.8 ± 0.2 | 1.8 ± 0.2 | 1.80 ±0 .24 | 0.68 |
| NYHA class III | 20(25.0%) | 7(20.6%) | 13(28.3%) | 0.4 |
| NYHA class IV | 23(28.7%) | 14(41.2%) | 9(19.6%) | 0.035 |
| DM | 46(57.5%) | 23(67.6%) | 23(50.0%) | 0.11 |
| HTN | 56(70.0%) | 22(64.7%) | 34(73.9%) | 0.37 |
| Smoking | 16(20.3%) | 7(21.2%) | 9(19.6%) | 0.85 |
| Dyslipidemia | 18(22.5%) | 7(20.60%) | 11(23.9%) | 0.72 |
| Coronary artery disease | 44(55.0%) | 26(76.5%) | 18(39.1%) | 0.001 |
| Syncope | 7(8.8%) | 1(2.9%) | 6(13.0%) | 0.11 |
| Life status (Expired) | 14(17.5%) | 6(17.6%) | 8(17.4%) | 0.97 |
| CVA | 4(5.0%) | 3(8.8%) | 1(2.2%) | 0.17 |
| Blood transfusion | 26(32.5%) | 13(38.2%) | 13(28.3%) | 0.3 |
| Bleeding | 76(95.0%) | 33(97.1%) | 43(93.5%) | 0.46 |
| Logistic EURO SCORE (%) | 14.8 ± 14 | 19.7 ± 13.8 | 11.2 ± 13.1 | 0.006 |
| Admission duration | 12.1 ± 8.6 | 12.9 ± 10.3 | 11.6 ± 7.2 | 0.5 |
| Procedure duration | 36.8 ± 12.1 | 35.6 ± 10.7 | 37.7 ± 13.2 | 0.47 |
BSA, Body Surface Area; BMI, body mass index; NYHA, New York Heart Association, DM, Diabetes millets, HTN: hypertension, CVA, cerebrovascular accident.
Data expressed as mean ± SD or as frequency (Number-percent).
SD: standard deviation P: Probability.
significance <0.05.
Echocardiographic parameters before and after TAVI according to baseline LVEF.
| Echocardiographic parameter | LVEF<50% Group A (n = 34)
| P | LVEF ≥50% Group B (n = 46)
| P | ||
|---|---|---|---|---|---|---|
| Pre-TAVI | Post-TAVI | Pre-TAVI | Post-TAVI | |||
| AVMG | 39.4 ± 15.5 | 9.80 ± 5.42 | <0.001 | 52.8 ± 20.0 | 11.09 ± 6.12 | <0.001 |
| LVOT VTI | 17.08 ± 3.98 | 19.13 ± 4.44 | 0.013 | 23.85 ± 6.59 | 23.18 ± 5.85 | 0.484 |
| AV VTI | 83.38 ± 28.68 | 37.60 ± 10.39 | <0.001 | 105.86 ± 22.74 | 38.72 ± 7.81 | <0.001 |
| SV | 61.92 ± 19.50 | 68.95 ± 22.21 | 0.025 | 81.09 ± 23.21 | 78.44 ± 20.18 | 0.417 |
| SVI | 34.88 ± 11.01 | 39.21 ± 14.01 | 0.020 | 45.54 ± 13.54 | 44.48 ± 13.81 | 0.557 |
| LVEDd | 4.96 ± 0.74 | 4.86 ±0 .68 | 0.4 | 4.76 ± 0.74 | 5.51 ± 4.93 | 0.3 |
| LVESd | 3.94 ± 0.76 | 3.45 ±0 .72 | <0.001 | 3.15 ± 0.67 | 3.68 ± 3.86 | 0.35 |
| IVSd | 1.55 ± 1.86 | 1.22 ±0 .18 | 0.3 | 8.99 ± 6.77 | 1.60 ± 2.03 | <0.001 |
| LVEF | 34.7 ± 10% | 49 ± 13% | <0.001 | 63.8 ± 7.1% | 64 ± 7% | 0.85 |
| AVA | 0.719 ±0 .295 | 1.87 ±0 .44 | <0.001 | 0.728 ±0 .211 | 2.10 ±0 .76 | <0.001 |
| Max PG | 63.82 ± 23.33 | 18.67 ± 9.86 | <0.001 | 89.64 ± 32.47 | 24.22 ± 19.13 | <0.001 |
| RV TAPSE | 3.52 ± 4.93 | 13.50 ± 9.44 | <0.001 | 2.93 ± 4.51 | 15.71 ± 9.78 | <0.001 |
| TDItri S'velocity | 10.48 ± 3.89 | 10.85 ± 3.84 | 0.664 | 12.66 ± 4.20 | 12.46 ± 2.57 | 0.77 |
| PASP | 55.03 ± 11.97 | 39.65 ± 11.46 | <0.001 | 46.13 ± 14.84 | 37.80 ± 11.83 | <0.001 |
AVMG: aortic valve mean gradient, LVOT VTI: left ventricular outflow tract velocity time integral, AV VTI: aortic valve velocity time integral, SV: stroke volume, SVI: stoke volume index, LVEDd: left ventricular end diastolic dimensions, LVESd: left ventricular end systolic dimensions, IVSd: interventricular septum in diastoleLVEF%: left ventricular ejection fraction, AVA: aortic valve area, RV TAPSE: right ventricular tricuspid annular plane systolic excursion, TDI tri S': tissue Doppler imaging lateral tricuspid annulus S wave velocity; PASP: pulmonary artery systolic pressure.
Data expressed as mean ± SD. SD: standard deviation P: Probability
significance <0.05.
Myocardial mechanics before and after TAVI according to baseline LV function.
| Group 1 LVEF<50% (n = 34)
| P | Group II LVEF ≥50% (n = 46)
| P | |||
|---|---|---|---|---|---|---|
| Pre-TAVI | Post-TAVI | Pre-TAVI | Post-TAVI | |||
| GLS (%) | −9.9 ± 3.9 | −11.9 ± 3.2 | 0.001 | −13.8 ± 3.1 | −15.2 ± 3.3 | <0.001 |
| GLSR (sec-1) | −0.5 ± 0.2 | −0.6 ± 0.2 | <0.001 | −0.7 ± 0.2 | −0.8 ± 0.2 | 0.005 |
| Circumferential strain base | −15.4 ± 5.2 | −17.5 ± 5.5 | 0.017 | −22.5 ± 8.1 | −23.9 ± 11.3 | 0.433 |
| Circumferential strain med | −14.8 ± 7.3 | −19.6 ± 6.7 | 0.001 | −25.5 ± 7.7 | −25.7 ± 7.7 | 0.769 |
| Circumferential strain apex | −18.7 ± 11.0 | −22.0 ± 12.2 | 0.102 | −35.9 ± 11.5 | −32.10 ± 9.20 | 0.024 |
| Global circumferential strain (%) | −16.30 ± 6.34 | −19.71 ± 6.27 | 0.003 | −28.2 ± 7.0 | −27.2 ± 6.3 | 0.210 |
| Circumferential strain rate base | −0.82 ± 0.25 | −1.06 ± 0.37 | 0.001 | −1.71 ± 2.95 | −1.38 ± 0.49 | 0.461 |
| Circumferential strain rate med | −0.82 ± 0.44 | −1.20 ± 0.46 | 0.001 | −1.97 ± 3.92 | −1.60 ± 0.65 | 0.503 |
| Circumferential strain rate apex | −1.24 ± 0.84 | −1.57 ± 0.78 | 0.089 | −2.77 ± 3.07 | −2.49 ± 1.75 | 0.572 |
| Global circumferential strain rate (sec –1) | −0.96 ± 0.44 | −1.28 ± 0.45 | 0.004 | −2.13 ± 3.25 | −1.82 ± 0.77 | 0.508 |
| Rotation (°) Base | −3.4 ± 4.1 | −5.8 ± 5.4 | 0.005 | −6.9 ± 3.7 | −5.1 ± 3.1 | 0.007 |
| Rotation (°) Apex | 5.7 ± 5.8 | 7.2 ± 4.1 | 0.006 | 13.5 ± 6.3 | 9.6 ± 7.6 | 0.009 |
| Peak twist angle (°) | 8.2 ± 7.0 | 12.98 ± 6.95 | 0.005 | 19.6 ± 8.8 | 14.2 ± 9.2 | 0.006 |
Data expressed as mean ± SD.
SD: standard deviation P: Probability.
significance <0.05.
Fig. 1Pre versus post TAVI longitudinal strain in a representative patient with EF 58%. Segmental longitudinal strain curves (apical 3 chamber view) are illustrated. Longitudinal systolic strain is reduced at baseline (8%), with improvement after TAVI (12.5%).
Fig. 2Pre versus post TAVI LV apical circumferential strain and circumferential strain rate in representative patient with EF 20% that improved to 56%. The apical CS increased from 6% to 31.8% and apical CSR increased from −0.4 sec-1 to −2.2sec-1.
Fig. 3Pre versus post TAVI rotation and net twist angle in a representative patient with LVEF 20%. Basal clockwise and apical counterclockwise rotation illustrated. Twist angle increased from 8º to 16º with improved EF to 56%.